AI assistant
Dare Bioscience, Inc. — Director's Dealing 2015
Jun 30, 2015
34825_dirs_2015-06-30_d651ee26-8a1f-4fbd-a62b-6c1ac83cf639.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2015-06-26
Reporting Person: FRIEDMAN PAUL A (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-06-26 | Stock Option (Right to Buy) | $4.78 | A | 8214 | Acquired | 2025-06-25 | Common Stock (8214) | Direct |
| 2015-06-26 | Stock Option (Right to Buy) | $4.78 | A | 11000 | Acquired | 2025-06-25 | Common Stock (11000) | Direct |
Footnotes
F1: This option was granted June 26, 2015. One-third of the shares underlying this option were vested on the date of grant and the remaining shares vest in two equal parts on the second and third anniversaries of the date Dr. Friedman was elected to serve as a director of the Company, January 27, 2016 and January 27, 2017, respectively.
F2: This option was granted on June 26, 2015. The shares vest in full on the earlier of June 26, 2016 or immediately prior to the Corporation's 2016 annual meeting of stockholders, subject to Dr. Friedman's continued service as a director of the Corporation through such date.